期刊
THROMBOSIS AND HAEMOSTASIS
卷 121, 期 4, 页码 422-432出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0040-1718729
关键词
race; antiplatelet therapy; direct oral anticoagulants; ischemic risk; bleeding risk
资金
- Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Science, ICT, and Future Planning [NRF-2015R1A5A2008833]
East Asian patients exhibit unique risk-benefit trade-offs in antithrombotic therapies compared to Caucasian patients, necessitating further research to guide future treatment strategies.
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y (12) receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据